Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

5685.0000 -1.50 (-0.03%)

NSE Nov 28, 2025 15:31 PM

Near 52W High of ₹5868.00

Volume: 57,067

Alkem Laboratories Ltd.

08 Nov 2023

5685.00

-0.03%

Alkem Labs (HOLD): Sizeable margin gains; tax guided to reduce raise to HOLD

Hold: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Q2 EBITDA/PAT outstripped consensus by 44%/54% on higher margins, strong US growth and low taxes

Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.